Imunon Appoints James E. Dentzer to its Board of Directors :

03.10.2022 - CEO of Curis brings extensive biopharmaceutical financial experience to the Board LAWRENCEVILLE, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) - Imunon, Inc. (Nasdaq: IMNN), a clinical-stage drug development company, announces the appointment of James E. ... Seite 1

Related Keywords

Michaelh Tardugno , Jamese Dentzer , , Board Of Directors Curis Inc , Imunon Inc Nasdaq , Valeritas Inc , Biogen Inc , Amicus Therapeutics Inc , Curis Inc , Dicerna Pharmaceuticals Inc , Chief Executive Officer , Curi Chief Operating Officer , Chief Financial , From March , Curi Chief Administrative Officer , Chief Financial Officer , Dicerna Pharmaceuticals , Amicus Therapeutics , Corporate Controller , Pont De Nemours , Executive Chairman ,